LITS (Lite Strategy) Pretax Margin %: % (As of Mar. 2026)

What is Lite Strategy Pretax Margin %?

Lite Strategy LITS +9.89% 22 Pretax Margin % is % as of Mar. 2026. GuruFocus rates LITS with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 946 Biotechnology companies, Lite Strategy ranks worse than 105708.14% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Lite Strategy's Pre-Tax Income for the three months ended in Mar. 2026 was $-23.69 Mil. Lite Strategy's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Lite Strategy's pretax margin for the quarter that ended in Mar. 2026 was %.

The historical rank and industry rank for Lite Strategy's Pretax Margin % or its related term are showing as below:

LITS's Pretax Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -90.5
* Ranked among companies with meaningful Pretax Margin % only.

Lite Strategy (NAS:LITS) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Lite Strategy Pretax Margin % Related Terms

Lite Strategy Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Lite Strategy's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lite Strategy Pretax Margin % Chart

Lite Strategy Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Pretax Margin %

Get a 7-Day Free Trial

-118.71

-133.80

-65.22

27.23

0.00

Lite Strategy Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Pretax Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

LITS vs DARE, ALGS, TVGN: Pretax Margin % Comparison

For the Biotechnology subindustry, Lite Strategy's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lite Strategy Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lite Strategy's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Lite Strategy's Pretax Margin % falls into.

Save Embed

22GF Score

Lite Strategy Inc LITS

Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Lite Strategy Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Lite Strategy's Pretax Margin for the fiscal year that ended in Jun. 2025 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Jun. 2025 )	/	Revenue (A: Jun. 2025 )
	=	-15.945	/	0
	=	%

Lite Strategy's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-23.694	/	0
	=	%

Frequently Asked Questions Learn more about Pretax Margin % →

What does a Pretax Margin % of % mean?

Lite Strategy (LITS) has a Pretax Margin % of % as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Lite Strategy and its competitors. According to the industry distribution chart, Lite Strategy ranks #999999 out of 946 companies in the Biotechnology industry.

Is Lite Strategy's Pretax Margin % too high?

Lite Strategy's current Pretax Margin % is %. Based on the distribution chart, Lite Strategy ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Lite Strategy has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.

How does Lite Strategy's Pretax Margin % compare to DARE and ALGS?

According to the Biotechnology industry distribution chart, Lite Strategy ranks #999999 out of 946 companies for Pretax Margin %. This places Lite Strategy in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Pretax Margin % for a Biotechnology company?

A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Pretax Margin % mean?

A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Lite Strategy and its competitors. Lite Strategy's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Lite Strategy stock overvalued right now?

Lite Strategy (LITS) has a current Pretax Margin % of %. The current Pretax Margin % is %. Lite Strategy's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Pretax Margin % calculated?

Pretax Margin % is calculated from a company's financial statements. For Lite Strategy (LITS), the current Pretax Margin % is % as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lite Strategy Business Description

Industry Healthcare Biotechnology

Comparable Companies DARE ALGS TVGN BOLD PLRZ ABVC TVRD GRDX INMB APLM VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges 0JW9:UK

Address 9920 Pacific Heights Boulevard, Suite 150, San Diego, CA, USA, 92121

Website https://www.litestrategy.com

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

22GF Score

Get the complete analysis for LITS

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90

Price

View LITS Analysis

See Pretax Margin % data for all stocks →